AJIC: American Journal of Infection Control
Volume 38, Issue 5 , Pages 354-360 , June 2010

Inactivation of influenza A virus H1N1 by disinfection process

  • Eun Kyo Jeong, BS
    • ,
  • Jung Eun Bae, BS
    • ,
  • In Seop Kim, PhD

      Affiliations

    • Corresponding Author InformationAddress correspondence to In Seop Kim, PhD, Department of Biological Sciences, Hannam University, Daejeon 305-811, South Korea.

References 

  1. Chang L-Y, Shih S-R, Shao P-L, Huang DT-N, Huang L-M. Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc. 2009;108:526–532
  2. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201
  3. Naffakh N, van der Werf S. April 2009: an outbreak of swine-origin influenza A (H1N1) virus with evidence for human-to-human transmission. Microbes Infect. 2009;11:725–728
  4. World Health Organization. Pandemic (H1N1) 2009—update 76, disease outbreak news, global alert and response, programmes and projects. Available from: http://www.who.int/csr/don/2010_02_26/en/index.html. Accessed March 11, 2010.
  5. Peiris JS, Poona LLM, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009;45:169–173
  6. Flint SJ, Enquist LW, Racaniello VR, Skalka AM. Principles of virology. 3rd ed.. Washington, DC: ASM Press; 2009;p. 511-3
  7. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152–179
  8. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis. 2002;2:145–155
  9. Voirin N, Barret B, Metzger MH, Vanhems P. Hospital-acquired influenza: a synthesis using the Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement. J Hospital Infect. 2009;71:1–14
  10. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hospital Infect. 2009;73:378–385
  11. Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. 2008;8:101–113
  12. Wu HM, Fornek M, Schwab KJ, Chapin AR, Gibson K, Schwab E, et al. A norovirus outbreak at a long-term-care facility: the role of environmental surface contamination. Infect Control Hosp Epidemiol. 2005;26:802–810
  13. Kärber J. Beitrag zur kollectiven Behandlung pharmakologische Reihenversuche. Arch Exp Path Pharmak. 1931;162:480–483
  14. Kim IS, Choi YW, Kang Y, Sung HM, Shin JS. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma. J Microbiol Biotechnol. 2008;18:997–1003
  15. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH. Survival of influenza viruses on environmental surfaces. J Infect Dis. 1982;146:47–51
  16. McDonnell GE. Antisepsis, disinfection, and sterilization. Washington, DC: ASM Press; 2007;p. 83-5
  17. Boschetti N, Wyss K, Mischler A, Hostettler T, Kempf C. Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals. 2003;31:181–185
  18. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12:147–179
  19. Morton HE. Alcohols. In:  Bloch SS editors. Disinfection, sterilization, and preservation. 3rd ed. Philiadelphia: Lea & Febiger; 1983;p. 225–239
  20. McDonnell GE. Antisepsis, disinfection, and sterilization. Washington, DC: ASM Press; 2007;p. 90-2
  21. Engelenburg FAC, Terpstra FG, Schuitemaker H, Moorer WR. The virucidal spectrum of a high concentration alcohol mixture. J Hospital Infect. 2002;51:121–125
  22. Eterpi M, McDonnell G, Thomas V. Disinfection efficacy against parvoviruses compared with reference viruses. J Hospital Infect. 2009;73:64–70
  23. Kim IS, Eo HG, Chang CE, Lee S. Partitioning and inactivation of viruses by cold ethanol fractionation and pasteurization during manufacture of albumin from human plasma. J Microbiol Biotechnol. 2000;10:858–864
  24. Horowitz B, Lazo A, Grossberg H, Page G, Lippin A, Swan G. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma. Vox Sang. 1998;74(Suppl 1):203–206
  25. Horowitz MS, Rooks C, Horowitz B, Hilgartner MW. Virus safety of solvent/detergent treated antihemophilic factor concentrates. Lancet. 1986;2:186–189
  26. Kim IS, Bae JE, Sung HM, Kang Y, Choi YW. Removal and inactivation of viruses during the manufacture of a high-purity antihemophilic factor IX from human plasma. Biotechnol Bioprocess Eng 2009;14: In Press.
  27. Kim IS, Choi YW, Lee SR, Woo HS, Lee S. Removal and inactivation of viruses during manufacture of a high-purity antihemophilic factor VIII concentrate from human plasma. J Microbiol Biotechnol. 2001;11:497–503
  28. McDonnell GE. Antisepsis, disinfection, and sterilization. Washington, DC: ASM Press; 2007;p. 55-62
  29. Borove S, Broumis C, Adcock W, Fang R, Uren E. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat. Biologicals. 1998;26:237–244
  30. Shahid MA, Abubakar M, Hameed S, Hassan S. Avian influenza virus (H5N1); effects of physico-chemical factors on its survival. BMC Virol J. 2009;6:38
  31. Swayne DE, Beck JR. Heat inactivation of avian influenza and Newcastle disease viruses in egg products. Avian Pathol. 2004;33:512–518
  32. McDonnell GE. Antisepsis, disinfection, and sterilization. Washington, DC: ASM Press; 2007;p. 191-7
  33. Mendes GCC, Brandão TRS, Silva CL. Ethylene oxide sterilization of medical devices: a review. Am J Infect Control. 2007;9:574–581
  34. Rutala WA, Gergen MF, Weber DJ. Comparative evaluation of the sporicidal activity of new low-temperature sterilization technologies: ethylene oxide, 2 plasma sterilization systems, and liquid peracetic acid. Am J Infect Control. 1998;26:393–398
  35. Moore TM, Gendler E, Gendler E. Viruses adsorbed on musculoskeletal allografts are inactivated by terminal ethylene oxide disinfection. J Orthop Res. 2004;22:1358–1361
  36. Alphin RL, Johnson KJ, Ladman BS, Benson ER. Inactivation of avian influenza virus using four common chemicals and one detergent. Poult Sci. 2009;88:1181–1185
  37. Seo SH, Jo SK, Kim HM, Lee CJ, Lee JS. Inactivation of avian influenza viruses by alkaline disinfectant solution. J Life Sci. 2007;17:340–344
  38. Rice EW, Adcock NJ, Sivaganesan M, Brown JD, Stalknecht DE, Swayne DE. Chlorine inactivation of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis. 2007;13:1568–1570
  39. Lombardi ME, Ladman BS, Alphin RL, Benson ER. Inactivation of avian influenza virus using common detergents and chemicals. Avian Dis. 2008;52:118–123

 Conflicts of interest: None to report.

 Supported by the Ministry of Education, Science Technology (MEST) and Korea Institute for Advancement of Technology (KIAT) through the Human Resources Training Project for Regional Innovation and by the Ministry of Knowledge Economy (MKE) and Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Strategic Technology.

PII: S0196-6553(10)00187-2

doi: 10.1016/j.ajic.2010.03.003

AJIC: American Journal of Infection Control
Volume 38, Issue 5 , Pages 354-360 , June 2010

Article Tools